15 maj: Pandora regnskab kostede aktionærerne mere end 11 mia. kr.
15 maj: NNIT: Overrasket over fald i Novo-indtægter, men stærk vækst elle..
15-05-2018 17:23:06

NNIT A/S: 07/2018 Financial report for Q1 2018

Relateret indhold
09:07 - 
NNIT samarbejder med amerikanere om cloud-løsning
10 aug - 
Aktier/middag: Novozymes og Mærsk fører an i C25-fald
10 aug - 
NNIT/Nordea: Anbefaling løftes til "hold" fra "sælg"

Financial report for Q1 2018

NNIT delivers an operating profit margin of 8.7% while revenue declines by 2.3% despite a revenue increase of 12% from non-Novo Nordisk customers

Performance highlights for Q1 2018

  • Revenue from non-Novo Nordisk customers increased by 12% supported by strong growth from both enterprise and international life sciences customers of more than 20%. However, due to decline in revenue from the Novo Nordisk Group of 20% and the timing of Easter total revenue declined by 2.3% in reported currencies

  • Adjusted for the timing of Easter revenue development was almost flat  

  • The share of revenue from non-Novo Nordisk customers increased from 55 % in Q1 2017 to 63% in Q1 2018

  • Operating profit margin was 8.7% in reported currencies compared to 10.5% in 2017 

  • Adjusting for the timing of Easter the operating profit margin was 10.5%

  •  Net profit of DKK 46m in Q1 2018 was a decrease of 18% compared to Q1 2017. Adjusted for the timing of Easter net profit increased by 1.4% compared to last year

  •  Free cash flow for Q1 2018 was DKK 143m compared to DKK 163m in Q1 2017

  •  Order backlog for 2018 at the beginning of Q2 2018 was DKK 2,487m, an increase of 2.8% compared to the same time last year. The backlog for the following two years increased by 20%

  • Outlook for 2018 is:

    • Revenue growth of 3-6% in constant currencies (previously 4-7%)

    • Expected operating profit margin of 10-10.5% in constant currencies

    • The expected level of investments in 2018 is 6-8% of total revenue

  • Based on the strong cash flow NNIT will pay out an interim dividend in August 2018 of DKK 49.1m in cash equal to DKK 2 per share of a nominal value of DKK 10

Per Kogut, CEO at NNIT says about the results for the first three months of 2018: "I am encouraged by the continued strong growth in particular the enterprise and international life sciences customer groups. The decline in revenue from the Novo Nordisk Group was larger than expected and we have therefore adjusted our revenue growth guidance for 2018 to 3-6%. Under these circumstances, I am pleased that we have maintained our operating profit margin guidance of 10-10.5%."

Conference call details

NNIT will host a teleconference May 16, 2018 at 10:30 CET about the financial report for Q1 2018. Please visit the NNIT webpage at www.nnit.com to access the teleconference, which can be found under 'Investors - Events & presentations'. Presentation material will be available on the website approximately one hour prior to the start of the presentation.

Conference call details

https://nnit.eventcdn.net/20180516

Participant telephone numbers:

Denmark:                     +45 3544 5583

United Kingdom:           +44 20 3194 0544

Sweden:                       +46 8 5664 2661

United States:               +1 855 269 2604

  

Financial Calendar 2018

August 17, 2018       Interim report for the first six months of 2018

 

August 22, 2018       Interim dividend ex dividend date

 

August 23, 2018       Interim dividend record date

 

August 24, 2018       Interim dividend payment date

 

October 25, 2018      Interim report for the first nine months of 2018

Contacts for further information

Investor relations:

Klaus Hosbond Skovrup

Head of Investor Relations

Tel: +45 3079 5355

ksko@nnit.com

Media relations:

Helga Heyn

NNIT Communications

Tel: +45 3077 8141

hhey@nnit.com

Company announcement Q1 2018 EN


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: NNIT A/S via Globenewswire

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

NKT OPTAKT Q2 15/8: Priser, guidance og 2019-indikationer i fokus

14-08-2018 11:30:02
Når kabelkoncernen NKT onsdag aflægger regnskab for andet kvartal vil der være fokus på, om selskabet ændrer på forventningerne til 2018. Derudover vil opmærksomheden rette sig mod eventuelle kommentarer om udsigterne for 2019, herunder prisudviklingen og mulighederne for at få flere ordrer i bogen for at sikre en bedre udnyttelse af selskabets produktionskapacitet.Hos Jyske Bank venter aktieanaly..

Aktier/tendens: Nilfisks regnskab og flere opjusteringer i fokus

14-08-2018 08:40:16
Et regnskab fra Nilfisk og flere selskaber med opjusteringer kan præge udviklingen på den københavnske fondsbørs tirsdag morgen blandt de mindre selskaber, der ikke er med i eliteindekset, C25.Her er det så som så med nyheder - måske lige med undtagelse af Vestas, der fra morgenstunden har fået nyt fra de tyske konkurrenter Senvion og Nordex, der begge er kommet med regnskaber, op til at Vestas se..

GN/CEO: Nyt produkt har en vigtig rolle i at nå vækstforventninger -NY

13-08-2018 15:41:26
Selv om det kom som en overraskelse for markedet, at GN Group mandag offentliggjorde planerne om lanceringen af et nyt høreapparat, så har det hele tiden været planen internt i høreapparatkoncernen, at det nye premiumapparat skulle lanceres efter sommer.Den kommende lancering af produktet, der går under navnet Resound Linx Quattro, kommer derfor heller ikke sammen med en ændring af vækstforventnin..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Veloxis Q2: Opjusterer forventninger efter højere produktomsætning
2
Mandagens aktier: GN og Coloplast bragte C25 i europæisk førerfelt
3
Aktier/tendens: Nilfisks regnskab og flere opjusteringer i fokus
4
KORR: Aktier/middag: Nilfisk straffes og opjusteringer belønnes
5
Valuta/Danske: Erdogans budskab får liraen til at miste pusten

Relaterede aktiekurser

Nnit A/S 165,40 0,2% Stigning i aktiekurs
Nnit Ord Shs 166,20 0,7% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
14. august 2018 15:39:21
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180810.1 - EUROWEB6 - 2018-08-14 15:39:21 - 2018-08-14 15:39:21 - 1 - Website: OKAY